What should be documented in sponsor agreements?

• A. Agreements with investigators, service providers, and other parties involved in the clinical trial should be documented prior to initiating activities.
• B. Protocol amendments.
• C. Financial budgets.
• D. Regulatory submissions.

Answer: (A)

The key idea is that sponsor agreements must be in writing with all parties involved in the trial before any activities start. These written agreements lay out who is responsible for what—investigators, sites, service providers, and other vendors—and define the terms of oversight, safety reporting, data handling, confidentiality, and compliance. By documenting these relationships and obligations upfront, the sponsor sets clear expectations, allocates responsibilities, and helps ensure the trial runs ethically and according to GCP and regulatory requirements.

While protocol amendments, budgets, and regulatory submissions are important elements of trial conduct, they are separate processes. Protocol amendments are changes to the study plan that require approvals; budgets are part of the contractual details but not the primary purpose of the agreement itself; regulatory submissions are communications to authorities, not the contracts governing the trial relationships.